Metraipolis › archive › dc_e646cd3d7041
Intraductal Papillary Mucinous Neoplasms and GLP-1 Receptor Agonists: Navigating Therapeutic Uncertainty in Diabetes Management — Europe PMC PMID:41153613
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41153613
- DOI
- 10.3390/biomedicines13102326
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T19:06:00.884Z
- SHA-256 of the archived text
0b85e6c2eb976035de0f65e62c987158d62d3ada9662219e9f638407b598399a- Stable URL of this page
https://metraipolis.com/documento/dc_e646cd3d7041
How to cite
Intraductal Papillary Mucinous Neoplasms and GLP-1 Receptor Agonists: Navigating Therapeutic Uncertainty in Diabetes Management — Europe PMC PMID:41153613 — Europe PMC (en), https://europepmc.org/article/MED/41153613 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e646cd3d7041 (Metraipolis archive dc_e646cd3d7041, sha256 0b85e6c2eb976035de0f65e62c987158d62d3ada9662219e9f638407b598399a)
BibTeX
@misc{dce646cd3d7041,
title = {Intraductal Papillary Mucinous Neoplasms and GLP-1 Receptor Agonists: Navigating Therapeutic Uncertainty in Diabetes Management — Europe PMC PMID:41153613},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41153613},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e646cd3d7041; sha256 0b85e6c2eb976035de0f65e62c987158d62d3ada9662219e9f638407b598399a},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41153613. Agents can read the archived copy with the MCP tool read_document.